Pharmacotherapy of Autism: A Review and Clinical Approach

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Developmental and Physical Disabilities

• Publication date

  2001-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1016686802786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Autism, profound mental retardation and atypical bipolar disorder in a 33-year-old female with a deletion of 15q12.

  2008cited by this paper
• Time trends in autism and in MMR immunization coverage in California.

  2001cited by this paper
• Venlafaxine in Children, Adolescents, and Young Adults With Autism Spectrum Disorders: An Open Retrospective Clinical Report

  2000cited by this paper
• Long-Term Risperidone for Pervasive Developmental Disorder: Efficacy, Tolerability, and Discontinuation

  2000cited by this paper
• Effect of secretin on children with autism: a randomized controlled trial

  2000cited by this paper
• Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

  2000cited by this paper
• Secretin and Autism: A Two-Part Clinical Investigation

  2000cited by this paper
• Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.

  2000cited by this paper
• Augmentation of standard depression therapy.

  2000cited by this paper
• Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

  1999cited by this paper
• AHA Scientific Statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs.

  1999cited by this paper
• Brief Report: Two-Year Control of Behavioral Symptoms with Risperidone in Two Profoundly Retarded Adults with Autism

  1999cited by this paper
• Stimulant medications : Current knowledge and unmet needs in pediatrics psychopharmacology

  1999cited by this paper
• Paroxetine in autism.

  1999cited by this paper
• The prevalence of Gilles de la Tourette's syndrome in children and adolescents with autism.

  1999cited by this paper
• Nontricyclic antidepressants: current trends in children and adolescents.

  1999cited by this paper
• Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.

  1999cited by this paper
• Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

  1999cited by this paper
• Mood stabilizers in children and adolescents.

  1999cited by this paper
• Risperidone in the Treatment of Two Very Young Children with Autism

  1999cited by this paper
• Lessons from secretin.

  1999cited by this paper
• Antipsychotics in children and adolescents.

  1999cited by this paper
• Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.

  1999cited by this paper
• Anxiolytics, adrenergic agents, and naltrexone.

  1999cited by this paper
• Open-Label Quetiapine in the Treatment of Children and Adolescents with Autistic Disorder

  1999cited by this paper
• Naltrexone and communication skills in young children with autism.

  1999cited by this paper
• Critical review of tricyclic antidepressant use in children and adolescents.

  1999cited by this paper
• Attention-deficit/hyperactivity disorder: a life-span perspective.

  1998cited by this paper
• An open trial of risperidone in young autistic children.

  1998cited by this paper
• The antipsychotics. A pediatric perspective.

  1998cited by this paper
• Effects of fluoxetine treatment in young children with idiopathic autism

  1998cited by this paper
• The use of tricyclic antidepressants in children and adolescents.

  1998cited by this paper
• Behavioral Effects of Clomipramine on Prepubertal Boys With Autistic Disorder and Severe Mental Retardation

  1998cited by this paper
• High dose vitamin B6 and magnesium in treating autism: response to study by Findling et al.

  1998cited by this paper
• Psychopharmacology of ADHD: children and adolescents.

  1998cited by this paper
• Improved social and language skills after secretin administration in patients with autistic spectrum disorders.

  1998cited by this paper
• Olanzapine for autistic disorder with hyperactivity.

  1998cited by this paper
• A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

  1998cited by this paper
• Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation.

  1998cited by this paper
• Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

  1998cited by this paper
• Prevalence of psychotropic and anticonvulsant drug use among North Dakota group home residents.

  1997cited by this paper
• An Overview of Three Decades of Research in Pediatric Psychopharmacoepidemiology

  1997cited by this paper
• Naltrexone in young autistic children: replication study and learning measures.

  1997cited by this paper
• Risperidone and Explosive Aggressive Autism

  1997cited by this paper
• High-Dose Pyridoxine and Magnesium Administration in Children with Autistic Disorder: An Absence of Salutary Effects in a Double-Blind, Placebo-Controlled Study

  1997cited by this paper
• A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

  1996cited by this paper
• Fragile X Syndrome

  1996cited by this paper
• Brief report: Brain mechanisms in autism: Functional and structural abnormalities

  1996cited by this paper
• Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.

  1996cited by this paper
• Case study: comorbidity among Tourette's syndrome, autistic disorder, and bipolar disorder.

  1996cited by this paper
• Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.

  1996cited by this paper
• A pilot study of clomipramine in young autistic children.

  1996cited by this paper
• Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.

  1995cited by this paper
• The use of buspirone with aggressive behavior

  1995cited by this paper
• Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.

  1995cited by this paper
• Case study: corticosteroid treatment of language regression in pervasive developmental disorder.

  1995cited by this paper
• Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.

  1995cited by this paper
• A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder.

  1995cited by this paper
• The effect of clozapine on self-injurious behavior

  1995cited by this paper
• Prediction of response to methylphenidate among children with ADHD and mental retardation.

  1994cited by this paper
• Use of clonidine for behavioral control in an adult patient with autism.

  1994cited by this paper
• Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation

  1994cited by this paper
• Paroxetine for self-injurious behavior.

  1994cited by this paper
• CHILDREN WITH AUTISTIC SPECTRUM DISORDER AND A FAMILY HISTORY OF AFFECTIVE DISORDER

  1994cited by this paper
• Naltrexone in autistic children: behavioral symptoms and attentional learning.

  1993cited by this paper
• Vitamin E treatment of tardive dyskinesia.

  1993cited by this paper
• Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues.

  1993cited by this paper
• Brief report: Cases for an association between Tourette syndrome, autistic disorder, and schizophrenia-like disorder

  1993cited by this paper
• Brief report: A double-blind study of naltrexone in infantile autism

  1992cited by this paper
• Pocket Handbook of Psychiatric Drug Treatment

  1992cited by this paper
• Clonidine Treatment of Hyperactive and Impulsive Children with Autistic Disorder

  1992cited by this paper
• Epidemiology and comorbidity. The North Dakota prevalence studies of Tourette syndrome and other developmental disorders.

  1992cited by this paper
• Clomipramine in autism: preliminary evidence of efficacy.

  1992cited by this paper
• Differential response of seven subjects with autistic disorder to clomipramine and desipramine.

  1992cited by this paper
• Comorbidity and treatment planning: summary and future directions.

  1992cited by this paper
• Fluoxetine treatment of children and adults with autistic disorder and mental retardation.

  1992cited by this paper
• Fluoxetine in autism with depression.

  1991cited by this paper
• Indices of neural function in autism: clinical and biologic implications.

  1991cited by this paper
• Prevalence of psychoactive drug use among North Dakota group home residents.

  1991cited by this paper
• A case report of naltrexone treatment of self-injury and social withdrawal in autism

  1990cited by this paper
• Autism: Review of neurochemical investigation

  1990cited by this paper
• Seizure disorders in autism.

  1990cited by this paper
• Clinical effect of buspirone in autistic children.

  1989cited by this paper
• The effects of fenfluramine (Hydrochloride) on the behaviors of fifteen autistic children

  1989cited by this paper
• Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.

  1989cited by this paper
• Assessing independent and interactive effects of behavioral and pharmacologic interventions for a client with dual diagnoses.

  1989cited by this paper
• Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.

  1989cited by this paper
• Methylphenidate in children with seizures and attention-deficit disorder.

  1989cited by this paper
• Fenfluramine treatment of autism.

  1988cited by this paper
• Controversies in the Treatment of Autistic Children: Vitamin and Drug Therapy

  1988cited by this paper
• Epilepsy in autism and autisticlike conditions. A population-based study.

  1988cited by this paper
• Tardive and withdrawal dyskinesia in autistic children: a prospective study.

  1988cited by this paper
• Treatment of tardive dyskinesia.

  1988cited by this paper
• A clinical pharmacological approach to treating Tourette syndrome in children and adolescents.

  1988cited by this paper
• CASE STUDY Methylphenidate Treatment of Hyperactive Autistic Children

  1988cited by this paper
• Lithium responsive manic-like symptoms in two individuals with autism and mental retardation.

  1987cited by this paper
• Brain opioids and autism: An updated analysis of possible linkages

  1987cited by this paper
• Brief report: Open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults

  1987cited by this paper
• Lithium Carbonate in the Treatment of Two Patients with Infantile Autism and Atypical Bipolar Symptomatology

  1987cited by this paper
• Are Schizophreniform Symptoms Present in Attenuated Form in Children with Tourette Disorder and Other Developmental Disorders

  1987cited by this paper

• Yoga: A Multi-Dimensional Therapeutic Approach to Autism Spectrum Disorder

  2021cites this paper
• Autism Spectrum Disorder: Signaling Pathways and Prospective Therapeutic Targets

  2020cites this paper
• Understanding Autism Spectrum Disorder: An Overview

  2020cites this paper
• Autism Spectrum Disorder: Signaling Pathways and Prospective Therapeutic Targets

  2020cites this paper
• Spectrum of Neurodegeneration in Autism Spectrum Disorder

  2019cites this paper
• Brief outline on neurobiology of autistic spectrum disorders (ASD)

  2018cites this paper
• A Short Review on the Current Understanding of Autism Spectrum Disorders

  2016cites this paper
• Improving social responsiveness of children with autism spectrum disorder through neuro-physical exercise

  2015cites this paper
• Polypharmacy profiles and predictors among adults with autism spectrum disorders

  2012cites this paper
• Unsubstantiated treatments for individuals with autism

  2010cites this paper
• Comprehensive Treatment Packages for ASD: Perceived vs Proven Effectiveness

  2008cites this paper
• Evidence for Effectiveness of Treatments for Autism Spectrum Disorders In Children and Adolescents October 2008

  2008influential citation
• Autism Spectrum Disorders: Pharmacotherapy for Challenging Behaviors

  2008cites this paper
• Parental Experience with Treatments for Autism

  2007cites this paper
• Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder

  2007cites this paper
• Nicotinic cholinergic antagonists: a novel approach for the treatment of autism.

  2006cites this paper
• Internet survey of treatments used by parents of children with autism.

  2006cites this paper
• Medication Treatment Outcomes for School-Aged Children Diagnosed with Autism

  2006cites this paper
• Treatment of movement disorders in autism spectrum disorders

  2003cites this paper